7h
Zacks Investment Research on MSNAbbVie's Rinvoq Gets EU Nod for 8th Indication Giant Cell ArteritisAbbVie ABBV announced that the European Commission has granted marketing approval to its blockbuster drug Rinvoq for treating ...
Pfizer and GlaxoSmithKline have agreed to end a lawsuit over alleged patent infringement involving their competing ...
4d
Zacks Investment Research on MSNPharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits FailureThis week, the FDA approved Sanofi’s SNY hemophilia therapy, fitusiran, Novartis’ NVS Vanrafia for the reduction of ...
The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission ...
The agreement with the GKV-Spitzenverband – the national association of statutory health insurance funds – means that Hemgenix (etranacogene dezaparvovec) can now be reimbursed across Germany's health ...
NICE recommended Pfizer's Adcetris for NHS use in advanced Hodgkin lymphoma, citing strong trial data and a new discount agreement with Takeda.
The latest decision makes Pfizer's Abrysvo the first RSV vaccine approved for use in non-pregnant adults under 50 years of ...
NEW YORK, NY, USA I April 01, 2025 I Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing ...
Ryanair on Wednesday lost its fight against 650 million euros ($702 million) of Polish state aid granted to Polish airline ...
Pfizer’s RSV vaccine Abrysvo receives European approval to help protect adults aged 18-59 against RSV lower respiratory tract disease: New York Wednesday, April 2, 2025, 09:00 H ...
Pfizer's latest plot twist includes an expanded European nod for its RSV vaccine, ABRYSVO, and a new autoimmune collab with ...
Pfizer (NYSE:PFE) recently saw the European Commission expand the authorization for its RSV vaccine, ABRYSVO, to include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results